Insider Trading June 17, 2026 04:28 PM

MongoDB CFO Michael J Berry Executes $1.78 Million Stock Sale

Insider transaction comes amid strong financial performance and upward analyst revisions for the data infrastructure leader

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
MDB

MongoDB, Inc. (NASDAQ: MDB) Chief Financial Officer Michael J. Berry completed a transaction involving the sale of 5,000 shares of the company's common stock on June 15, 2026. The sale, which generated approximately $1.78 million, was executed under a Rule 10b5-1 trading plan. The transaction occurs as MongoDB reports significant financial outperformance in fiscal year 2027, prompting several financial institutions to raise their price targets for the stock.

MongoDB CFO Michael J Berry Executes $1.78 Million Stock Sale
MDB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • MongoDB CFO Michael J. Berry sold 5,000 shares for $1.78 million via a Rule 10b5-1 plan on June 15, 2026.
  • MongoDB reported Q1 FY2027 revenue outperformance of $23.1 million, with Atlas platform growth of 29% exceeding expectations.
  • Multiple financial firms raised price targets for MDB, citing strong consumption trends and leadership in AI data infrastructure.

Michael J. Berry, serving as the Chief Financial Officer for MongoDB, Inc. (NASDAQ: MDB), finalized the sale of 5,000 shares of the company's common stock on June 15, 2026. The transaction resulted in proceeds totaling approximately $1.78 million. The shares were sold at prices varying between $349.53 and $363.69 per share. At the time of reporting, the stock was trading at $334.57, which represents a decline from the price levels at which the sale occurred. Despite this recent dip, the stock maintains a substantial 69.65% gain over the trailing twelve months. Independent analysis indicates that MongoDB is currently trading near its estimated fair value, supported by a financial health score of 3.09 out of 5, categorized as "GREAT".

The 5,000 shares sold were not held directly by Mr. Berry. Instead, they were held indirectly through The Berry Family Trust, a revocable trust where Mr. Berry acts as a trustee. The execution of these sales was conducted under a Rule 10b5-1 trading plan. This structured arrangement is designed to allow corporate insiders to execute trades at predetermined times, thereby mitigating regulatory concerns regarding potential insider trading activities.

Following the completion of this transaction, Mr. Berry's indirect ownership of MongoDB common stock through the trust stands at 6,500 shares. His direct holdings include 84,820 shares. This direct portfolio includes 32 shares acquired through the company's Employee Stock Purchase Plan on the same date as the sale, June 15, 2026.

The insider transaction takes place against a backdrop of positive financial developments for MongoDB. The company reported a revenue outperformance of $23.1 million in the first quarter of fiscal year 2027. A primary driver of this result was the Atlas platform, which experienced a 29% growth rate. This growth rate surpassed management's internal projections of 26%.

These financial results have triggered adjustments to price targets from multiple financial firms. Stifel increased its price target to $435, citing the accelerated consumption trends and better-than-expected Atlas growth. Needham raised its target to $400, maintaining an Underperform rating but acknowledging the robust quarterly results. BofA Securities lifted its price target to $390, noting that MongoDB exceeded both its own and broader street expectations, leading to a raised full-year outlook. Tigress Financial Partners established a new price target of $515, emphasizing MongoDB's leadership in AI-powered data infrastructure. Cantor Fitzgerald reiterated its Overweight rating with a price target of $416, highlighting the company's strategic role in modernizing data architectures.

While the company's financial metrics and analyst sentiment show strength, the recent sale of shares by a key executive introduces a layer of market observation. The divergence between the sale prices and the current trading price of $349.53 to $363.69 versus $334.57 may reflect broader market volatility or sector-specific corrections. Investors monitor such insider transactions closely, as they can signal management's perspective on valuation, even when executed under pre-arranged plans.

Risks

  • The current stock price of $334.57 is below the sale price range of $349.53 to $363.69, indicating potential near-term volatility.
  • The reliance on Atlas platform growth for revenue outperformance highlights concentration risk within the company's product portfolio.
  • Analyst price targets vary significantly, ranging from $390 to $515, reflecting differing views on the company's future valuation and growth trajectory.

More from Insider Trading

Ciena CEO Gary B Smith Offloads $1.35M in Stock Amid Strong Q2 Performance Jun 17, 2026 BillionToOne CTO David Tsao Executes Pre-Arranged Stock Sale and Option Exercise Jun 17, 2026 BillionToOne Executive Sells Shares Under Pre-Arranged Plan Jun 17, 2026 Ciena Strategy Executive Divests Shares Under Pre-Arranged Plan Amid Market Rally Jun 17, 2026 Castle Biosciences CEO Derek Maetzold Executes Transactions Under Pre-Arranged Plan Jun 17, 2026